Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 1

Status

Completed 24Terminated 10Unknown 3Active not recruiting 3Recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Breast 1

Conditions

Neoplasms 2Seroma 1Hepatitis 1Chemical and Drug Induced Liver Injury 1Breast Neoplasms 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Interventional × Methylprednisolone Hemisuccinate × Clear all
NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown
60 enrolled

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

NCT00903188 2009-05-18

CISTCERT

University Hospital, Antwerp

Phase 4 Unknown
152 enrolled
Tumor-Agnostic

Neoplasms

NCT00307606 2007-09-06

Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma

Herlev Hospital

Phase 4 Unknown
40 enrolled
Breast

Breast Neoplasms, Seroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡